About Multiplex Genomics
Multiplex Genomics is a Canadian firm focused on developing methods that make it possible to scale up conventional COVID-19 testing and to identify the variants of this virus. Our capacity to undertake this work reflects expertise developed over the past 20 years at the Guelph’s Centre for Biodiversity Genomics, a global leader in the application of molecular methods for species identification.
Learn MoreCareer Opportunities
Join us in dramatically enhancing Canada's testing capacity for COVID-19 and other viruses. We are currently expanding our team and looking for talented technical staff to join our lab and informatics teams. Please contact us if you are interested in joining our mission.
Learn MoreTesting at Scale
Gold Standard Testing
Polymerase Chain Reaction (PCR) is the gold standard for viral detection and identification.
Automation + Acceleration
Using Multiplex Genomics’ leading-edge detection process and automation, we can scale and process tens of thousands of tests in an 12-hour period.
Quality Assurance
Our centralized, state-of-the-art facility establishes a rigorous system of quality control for all viral pathogen testing, providing accuracy and consistency in our tests.
Our approach
Our process is built from the ground up with a focus on end-to-end data integration and scalable laboratory methods. This allows us to offer a high volume of tests without compromising on quality.
AMAVI99: Terobosan Inovasi Terbaru untuk Analisis Teknologi Masa Depan
AMAVI99 adalah inovasi terbaru yang membawa terobosan dalam analisis teknologi masa depan. Dengan pemanfaatan pendekatan canggih dan solusi berbasis data, AMAVI99 memungkinkan analisis yang lebih akurat dan efisien. Terobosan ini membuka peluang baru untuk berbagai sektor, mempercepat pengambilan keputusan, dan mendukung perkembangan teknologi yang lebih maju.
